Montara Therapeutics is a preclinical-stage biopharmaceutical company pursuing novel approaches to develop safer and more efficacious treatments for neurological diseases. Montara's BrainOnly™ platform enables brain-specific pharmacology by leveraging existing and novel chemical warheads, restricting deleterious on-target / off-tissue peripheral activity. BrainOnly holds the potential to drug numerous targets previously considered undruggable greatly expanding the therapeutic options for patients in need of these therapies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/13/25 | $20,000,000 | Seed |
BEVC Dementia Discovery Fund Dolby Family Ventures KdT Ventures SV Health Investors Two Bear Capital | undisclosed |
